CTLA4 and autoimmune polyendocrine syndrome type 1: An overall trend towards lower amounts of HELIOS-expression and higher levels of CTLA-4- signals could be observed within the APS-1 cohort, but these observations did not reach statistical significance after multiple testing corrections (Figure 1A).